The CONFIDENCE Study: Impact of Timing, Headache Severity and Functional Impairment at Intake of Rimegepant on Pain Relief, Return to Function and Treatment Satisfaction
Karin Hygge Blakeman, Alexandre Urani, Giorgio Lambru3, Richard B Lipton,
Peter J Goadsby, Patricia Pozo-Rosich, Todd J. Schwedt, Kristina M Fanning,
Lucy Abraham
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Time Course of Rimegepant Effect for Acute Treatment of Migraine in Adults Unsuitable for Triptans: Exploratory Endpoints From a Phase 4 Randomized Double-Blind Placebo-Controlled Study
Michel Lanteri-Minet, Timothy Smith, Catherine Nalpas, Luz M Ramirez, Alexandra
Thiry6, Shannin McCollum, Sara Ramaker, Robert Fountaine
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
What is the consistency of response to rimegepant at a group level in the acute treatment of migraine in UK adult patients? Protocol for a real-world, patient-centred study
Grant O’Neil, Lucy Abraham, Robert Pawinski,KarinaNakajima, Emma Bagshaw, Alasdair Fellows, SamuelLlewellyn, Giorgio Lambru
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Migraine treatment outcomes with rimegepant in rimegepant-naive patients: a real-world, multi-center, prospective, observational study
Ye Ran M.D. Ph.D, Qian Zhao, Hui Su M.D., Ph.D, Shuhua Zhang M.D, Zizi He M.D, Yu Liu, Zhao Dong M.D, Ph.D, Shengyuan Yu M.D, Ph.D, on behalf of the ARISE Investigators
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
Changes in acute treatment effectiveness in migraine patients switching from standard of care to rimegepant: findings from a real-world study
Ye Ran M.D. Ph.D, Qian Zhao, Hui Su M.D., Ph.D, Shuhua Zhang M.D, Zizi He M.D, Yu Liu, Zhao Dong M.D, Ph.D, Shengyuan Yu M.D., Ph.D, on behalf of the ARISE Investigators
EHC 2025
- 欧洲头痛大会 2025
| 偏头痛
